Workup for Cushing's Syndrome
Begin the diagnostic workup by first excluding exogenous glucocorticoid use (oral, inhaled, topical, or injections), then proceed with 2-3 screening tests based on clinical suspicion level, followed by ACTH measurement to determine etiology. 1
Initial Assessment
Rule Out Exogenous Glucocorticoids
- Stop all exogenous glucocorticoid sources if possible before proceeding with diagnostic testing, as this is the most common cause of Cushing's syndrome 1, 2
- Review medications including oral steroids, inhalers, topical preparations, and injections 1
Clinical Features to Assess
Look specifically for these high-specificity findings 3, 4:
- Abnormal fat distribution: supraclavicular and temporal fossae fat pads, truncal obesity 3, 4
- Skin changes: wide purple striae (>1 cm), facial plethora, easy bruising 2, 3
- Proximal muscle weakness 3
- In children: decreased linear growth with continued weight gain 1, 3
- Additional features: buffalo hump, moon facies, hypertension, abdominal striae, centripetal fat distribution 1
Screening Tests (Step 1: Confirm Hypercortisolism)
Test Selection Based on Clinical Suspicion
For LOW clinical suspicion: 1
- Perform late-night salivary cortisol (≥2 tests on consecutive days) 1
For INTERMEDIATE or HIGH clinical suspicion: 1
Test-Specific Considerations
- Measuring dexamethasone level along with morning cortisol after 1 mg DST improves test interpretability 1
- DST is particularly useful in shift workers but should not be used in women taking estrogen-containing oral contraceptives 1
- Multiple LNSC collections may be easier for patient compliance 1
- If initial tests are abnormal, repeat 1-2 screening tests to confirm 1
Exclude Pseudo-Cushing States
If screening tests are abnormal, consider and exclude 1:
- Severe obesity
- Pregnancy
- Polycystic ovary syndrome (PCOS)
- Uncontrolled diabetes mellitus
- Anorexia/malnutrition
- Acute illness or recent surgery
- Excessive exercise
Consider additional tests like Dex-CRH test, DDAVP stimulation, or midnight serum cortisol if results are equivocal 1
Differential Diagnosis (Step 2: Determine Etiology)
Measure Plasma ACTH Level
Once hypercortisolism is confirmed, measure ACTH to distinguish between causes 1, 2:
LOW or SUPPRESSED ACTH = ACTH-independent Cushing's syndrome 1, 2
NORMAL or HIGH ACTH = ACTH-dependent Cushing's syndrome 1, 2
- Proceed to pituitary MRI 1
- Indicates Cushing's disease (pituitary adenoma) or ectopic ACTH secretion 2, 5
Further Localization for ACTH-Dependent Disease
Pituitary MRI Findings Guide Next Steps 1
Adenoma ≥10 mm: 1
- Presumed Cushing's disease—no IPSS needed (consensus) 1
Adenoma 6-9 mm: 1
- Gray zone—expert opinions differ; consider CRH and DDAVP testing or proceed to IPSS 1
Adenoma <6 mm or no adenoma/equivocal: 1
- Perform bilateral inferior petrosal sinus sampling (IPSS) with CRH or DDAVP stimulation 1, 3
- IPSS is the most accurate test to distinguish pituitary from ectopic ACTH secretion 3
- If ectopic source suspected, perform whole-body CT to locate ectopic ACTH-secreting tumor 1
Additional Screening Tests for Secondary Hypertension Workup
If evaluating Cushing's as part of secondary hypertension workup 1:
- 24-hour urinary cortisol or overnight dexamethasone suppression test 1
- Clinical clues: truncal obesity, glucose intolerance, purple striae, sudden onset or resistant hypertension 1
Pediatric Considerations
In children over age 6: 1
- Cushing's disease is the most common cause 1
- Use same screening tests: 24-hour UFC, LNSC, or overnight 1 mg DST 1
- Dex-CRH test is NOT useful in children 1
- IPSS role is more limited compared to adults 1
In children under age 6: 1
- Adrenal causes are more common than pituitary 1
Common Pitfalls
- Do not use DST in women on estrogen-containing contraceptives—falsely elevated cortisol-binding globulin affects results 1
- Avoid proton pump inhibitors (PPIs) when using ketoconazole for treatment—needs gastric acid for absorption 1
- Consider cyclic Cushing's—if initial tests normal but clinical suspicion high, periodically re-evaluate with repeat testing 1
- LNSC has lower specificity in patients with adrenal tumors 1
- Always measure dexamethasone levels with DST when possible to confirm adequate absorption 1